Connection
Evgenia Dobrinskikh to Hypolipidemic Agents
This is a "connection" page, showing publications Evgenia Dobrinskikh has written about Hypolipidemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.034 |
|
|
|
-
Wang XX, Luo Y, Wang D, Adorini L, Pruzanski M, Dobrinskikh E, Levi M. A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice. J Biol Chem. 2017 07 21; 292(29):12018-12024.
Score: 0.034